Clinical Trials
>
Renal Cell Cancer

B9991003

A Phase 3, Multinational, Randomized, Open-Label, Parallel-Arm Study of Avemumab (MSB0010718C) In combination with Axitinib (Inlyta®) Versus Sunitinib (Sutent®) Monotherapy In the First-Line Treatment of Patients With Advanced Renal Cell Carcinoma.

RTOG 0631

Phase II/III study of image guided radiosurgery/SBT for localized spine metastatis.